TRACON Pharmaceuticals, Inc.

TCON · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$4-$29-$29-$17
Dep. & Amort.$0$0-$0-$0
Deferred Tax$0$0-$0-$0
Stock-Based Comp.$2$2$2$1
Change in WC-$1-$0$5-$2
Other Non-Cash$6$1-$0$0
Operating Cash Flow$4-$26-$23-$17
Investing Activities
PP&E Inv.$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0-$4
Inv. Sales/Matur.$0$0$4$0
Other Inv. Act.$0$0$4-$4
Investing Cash Flow$0-$0$4-$4
Financing Activities
Debt Repay.-$21$12-$3-$1
Stock Issued$8$8$13$38
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow-$13$20$11$37
Forex Effect$0$0$0$0
Net Chg. in Cash-$9-$7-$8$16
Supplemental Information
Beg. Cash$18$24$32$16
End Cash$9$18$24$32
Free Cash Flow$4-$26-$23-$17
TRACON Pharmaceuticals, Inc. (TCON) Financial Statements & Key Stats | AlphaPilot